Lifevantage Corporation - Common Stock (LFVN)
18.80
-3.94 (-17.33%)
Lifevantage Corp is a biotechnology company that focuses on developing and marketing products designed to promote health and wellness through the activation of the body's natural processes
The company is known for its innovative nutritional supplements and skincare products that leverage the science of cellular health and longevity. By utilizing advanced research and development, Lifevantage aims to empower consumers to enhance their overall well-being and optimize their life's potential through targeted solutions.
![](https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp)
Wondering what's happening in Thursday's pre-market session? Find an overview in this article.
Via Chartmill · February 6, 2025
![](https://www.chartmill.com/images/uploads/CM_Aftermarket_Movers_Small_free_e077945a19.webp)
After the conclusion of the US market's regular session on Wednesday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
Via Chartmill · February 5, 2025
![](https://cdn.benzinga.com/files/images/story/2023/dividend_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · September 4, 2023
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · October 25, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · October 14, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · October 3, 2024
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
LFVN stock results show that Lifevantage beat analyst estimates for earnings per share but missed on revenue for the third quarter of 2024.
Via InvestorPlace · May 2, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · November 17, 2023
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
Companies Reporting Before The Bell • CommVault Systems (NASDAQCVLT) is estimated to report quarterly earnings at $0.73 per share on revenue of $208.06 million.
Via Benzinga · January 30, 2024
Nearly 300 Senior Marketing Consultants Announce Support for Existing LifeVantage Corporation (LFVN) Board of Directors
--News Direct--
Via News Direct · October 12, 2023
![](https://cdn.benzinga.com/files/images/story/2023/09/27/image22.jpeg?width=1200&height=800&fit=crop)
Although U.S. stocks closed lower on Tuesday, there were a few notable insider trades.
Via Benzinga · September 27, 2023
![](https://cdn.benzinga.com/files/images/story/2023/08/29/j._m._smucker_-_logo.jpg?width=1200&height=800&fit=crop)
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 250 points on Tuesday. The Dow traded up 0.74% to 34,814.53 while the NASDAQ rose 1.73% to 13,942.34. The S&P 500, also rose, gaining, 1.34% to 4,492.62.
Via Benzinga · August 29, 2023
![](https://cdn.benzinga.com/files/images/story/2023/08/29/nio_-_logo.jpg?width=1200&height=800&fit=crop)
Gainers Axcella Health Inc. (NASDAQAXLA) shares climbed 196% to $0.3335 after the company announced it was granted a patent for long COVID fatigue treatment.
Via Benzinga · August 29, 2023
![](https://cdn.benzinga.com/files/images/story/2023/08/29/image23.jpeg?width=1200&height=800&fit=crop)
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 200 points on Tuesday. The Dow traded up 0.57% to 34,758.68 while the NASDAQ rose 1.61% to 13,925.71. The S&P 500, also rose, gaining, 1.13% to 4,483.44.
Via Benzinga · August 29, 2023
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · July 4, 2023
![](https://cdn.benzinga.com/files/images/story/2023/06/16/image34.jpeg?width=1200&height=800&fit=crop)
The most overbought stocks in the consumer staples sector presents an opportunity to go short on these overvalued companies.
Via Benzinga · June 16, 2023
![](https://cdn.benzinga.com/files/images/story/2023/05/18/image28.jpeg?width=1200&height=800&fit=crop)
The most overbought stocks in the consumer staples sector presents an opportunity to go short on these overvalued companies.
Via Benzinga · May 18, 2023
![](https://cdn.benzinga.com/files/images/story/2022/roce_image_3087.jpeg?width=1200&height=800&fit=crop)
Benzinga Pro data, Lifevantage (NASDAQLFVN) reported Q4 sales of $50.94 million. Earnings fell to a loss of $1.42 million, resulting in a 224.1% decrease from last quarter.
Via Benzinga · September 13, 2022